Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System, Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Soldo D, Grizelj B, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I, Pharmaceuticals (Basel), Pharmaceuticals, 2025 Jun 19;18(6):928
Not intended for human clinical use or therapeutic administration
Last year she sent a letter to Kennedy calling on him to relax FDA restrictions on a half-dozen peptides
Research Mechanism In laboratory settings, BPC-157 is utilised to investigate: Angiogenesis: The upregulation of the VEGF (Vascular Endothelial Growth Factor) pathway to promote new blood vessel formation
Acta Pharmaceutica Sinica B, 15 (12), 63426381